Skip to main content

Table 1 Baseline characteristics of early- and late-stage colon cancer cohorts in the UK Biobank

From: Association of pre-diagnosis plasma proteomic contexture with overall survival of early- and late-stage colon cancer patients

Baseline characteristica

Early stage (316)

Late stage (278)

P value

Age at recruitment (year)

61.27 (6.41)

60.26 (6.78)

0.06

Age at diagnosis (year)

70.34 (7.40)

67.90 (7.32)

 < 0.001

Sex

 Male

183 (57.9)

145 (52.2)

0.18

 Female

133 (42.1)

133 (47.8)

 

 Ethnic (White %)

304 (96.5)

263 (96.0)

0.91

 BMI

27.98 (4.77)

27.87 (4.61)

0.77

 Year from baseline to diagnosis

8.56 (3.79)

7.15 (3.69)

 < 0.001

 Year from diagnosis to death

5.99 (3.89)

3.74 (3.85)

 < 0.001

Alcohol drinker status

 Never

19 (6.0)

11 (4.0)

0.54

 Previous

13 (4.1)

12 (4.3)

 

 Current

284 (89.9)

252 (90.6)

 

Smoking

 Never

146 (46.2)

149 (53.6)

0.12

 Previous

139 (44.0)

99 (35.6)

 

 Current

31 (9.8)

26 (9.4)

 

Survival status

 Alive

278 (88.0)

106 (38.1)

 < 0.001

 Death

38 (12.0)

172 (61.9)

 

Stageb

 III

-

63 (22.7)

-

 IV

-

215 (77.3)

 

Metastasis type

 Lymph node metastasis only

-

63 (22.7)

-

 Distant metastasis only

-

120 (43.2)

 

 Both types of metastases

-

95 (34.2)

 

Metastasis site

 Liver and intrahepatic bile duct

 

153 (55.0)

-

 Lung

 

83 (29.8)

 

 Retroperitoneum and peritoneum

 

80 (28.8)

 
  1. aN (%) or Mean (SD). BMI body-mass index
  2. bStage information is not available in the UK Biobank, only lymph node metastasis was used as proxy for stage III, and distant metastasis was used as proxy for stage IV